Iterum Therapeutics Plc Stock Volatility
| ITRM Stock | USD 1.81 0.04 2.26% |
Iterum Therapeutics is abnormally volatile given 3 months investment horizon. Iterum Therapeutics PLC holds Efficiency (Sharpe) Ratio of 0.12, which attests that the entity had a 0.12% return per unit of risk over the last 3 months. We were able to interpolate data for thirty different technical indicators, which can help you to evaluate if expected returns of 1.14% are justified by taking the suggested risk. Use Iterum Therapeutics PLC Market Risk Adjusted Performance of (0.61), risk adjusted performance of 0.0892, and Downside Deviation of 6.88 to evaluate company specific risk that cannot be diversified away. Key indicators related to Iterum Therapeutics' volatility include:
720 Days Market Risk | Chance Of Distress | 720 Days Economic Sensitivity |
Iterum Therapeutics Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Iterum daily returns, and it is calculated using variance and standard deviation. We also use Iterum's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Iterum Therapeutics volatility.
Iterum |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Iterum Therapeutics can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Iterum Therapeutics at lower prices. For example, an investor can purchase Iterum stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Iterum Therapeutics' stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.
Moving against Iterum Stock
| 0.76 | PFE | Pfizer Inc Aggressive Push | PairCorr |
| 0.76 | INZY | Inozyme Pharma | PairCorr |
| 0.73 | ME | 23Andme Holding | PairCorr |
| 0.69 | A | Agilent Technologies Earnings Call Today | PairCorr |
| 0.69 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.68 | LLY | Eli Lilly Sell-off Trend | PairCorr |
| 0.64 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
| 0.53 | IPSC | Century Therapeutics | PairCorr |
| 0.53 | LEGN | Legend Biotech Corp | PairCorr |
Iterum Therapeutics Market Sensitivity And Downside Risk
Iterum Therapeutics' beta coefficient measures the volatility of Iterum stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Iterum stock's returns against your selected market. In other words, Iterum Therapeutics's beta of -1.57 provides an investor with an approximation of how much risk Iterum Therapeutics stock can potentially add to one of your existing portfolios. Iterum Therapeutics PLC is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Iterum Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Iterum Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Iterum Therapeutics PLC Demand TrendCheck current 90 days Iterum Therapeutics correlation with market (Dow Jones Industrial)Iterum Beta |
Iterum standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 9.6 |
It is essential to understand the difference between upside risk (as represented by Iterum Therapeutics's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Iterum Therapeutics' daily returns or price. Since the actual investment returns on holding a position in iterum stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Iterum Therapeutics.
Iterum Therapeutics PLC Stock Volatility Analysis
Volatility refers to the frequency at which Iterum Therapeutics stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Iterum Therapeutics' price changes. Investors will then calculate the volatility of Iterum Therapeutics' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Iterum Therapeutics' volatility:
Historical Volatility
This type of stock volatility measures Iterum Therapeutics' fluctuations based on previous trends. It's commonly used to predict Iterum Therapeutics' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Iterum Therapeutics' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Iterum Therapeutics' to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Iterum Therapeutics PLC Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Iterum Therapeutics Projected Return Density Against Market
Given the investment horizon of 90 days Iterum Therapeutics PLC has a beta of -1.5749 . This usually indicates as returns on its benchmark rise, returns on holding Iterum Therapeutics PLC are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Iterum Therapeutics is expected to outperform its benchmark.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Iterum Therapeutics or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Iterum Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Iterum stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Iterum Therapeutics PLC has an alpha of 1.1706, implying that it can generate a 1.17 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Predicted Return Density |
| Returns |
What Drives an Iterum Therapeutics Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Iterum Therapeutics Stock Risk Measures
Given the investment horizon of 90 days the coefficient of variation of Iterum Therapeutics is 842.64. The daily returns are distributed with a variance of 92.24 and standard deviation of 9.6. The mean deviation of Iterum Therapeutics PLC is currently at 5.29. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.77
α | Alpha over Dow Jones | 1.17 | |
β | Beta against Dow Jones | -1.57 | |
σ | Overall volatility | 9.60 | |
Ir | Information ratio | 0.09 |
Iterum Therapeutics Stock Return Volatility
Iterum Therapeutics historical daily return volatility represents how much of Iterum Therapeutics stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 9.6042% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7685% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Iterum Therapeutics Volatility
Volatility is a rate at which the price of Iterum Therapeutics or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Iterum Therapeutics may increase or decrease. In other words, similar to Iterum's beta indicator, it measures the risk of Iterum Therapeutics and helps estimate the fluctuations that may happen in a short period of time. So if prices of Iterum Therapeutics fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.| Last Reported | Projected for Next Year | ||
| Selling And Marketing Expenses | 6.7 M | 6 M | |
| Market Cap | 25.5 M | 24.3 M |
Iterum Therapeutics' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Iterum Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Iterum Therapeutics' price varies over time.
3 ways to utilize Iterum Therapeutics' volatility to invest better
Higher Iterum Therapeutics' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Iterum Therapeutics PLC stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Iterum Therapeutics PLC stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Iterum Therapeutics PLC investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Iterum Therapeutics' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Iterum Therapeutics' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Iterum Therapeutics Investment Opportunity
Iterum Therapeutics PLC has a volatility of 9.6 and is 12.47 times more volatile than Dow Jones Industrial. Compared to the overall equity markets, volatility of historical daily returns of Iterum Therapeutics PLC is higher than 85 percent of all global equities and portfolios over the last 90 days. You can use Iterum Therapeutics PLC to enhance the returns of your portfolios. The stock experiences an unexpected upward trend. Watch out for market signals. Check odds of Iterum Therapeutics to be traded at $2.17 in 90 days.Good diversification
The correlation between Iterum Therapeutics PLC and DJI is -0.13 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Iterum Therapeutics PLC and DJI in the same portfolio, assuming nothing else is changed.
Iterum Therapeutics Additional Risk Indicators
The analysis of Iterum Therapeutics' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Iterum Therapeutics' investment and either accepting that risk or mitigating it. Along with some common measures of Iterum Therapeutics stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.0892 | |||
| Market Risk Adjusted Performance | (0.61) | |||
| Mean Deviation | 5.25 | |||
| Semi Deviation | 5.75 | |||
| Downside Deviation | 6.88 | |||
| Coefficient Of Variation | 958.6 | |||
| Standard Deviation | 9.49 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Iterum Therapeutics Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Iterum Therapeutics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Iterum Therapeutics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Iterum Therapeutics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Iterum Therapeutics PLC.
When determining whether Iterum Therapeutics PLC is a strong investment it is important to analyze Iterum Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Iterum Therapeutics' future performance. For an informed investment choice regarding Iterum Stock, refer to the following important reports: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Iterum Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Iterum Therapeutics. If investors know Iterum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Iterum Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.76) | Quarterly Revenue Growth (1.00) | Return On Assets (0.73) | Return On Equity (5.56) |
The market value of Iterum Therapeutics PLC is measured differently than its book value, which is the value of Iterum that is recorded on the company's balance sheet. Investors also form their own opinion of Iterum Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Iterum Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Iterum Therapeutics' market value can be influenced by many factors that don't directly affect Iterum Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Iterum Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Iterum Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Iterum Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.